Protalix biotherapeutics, inc. (PLX)
CashFlow / Yearly
Dec'19Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11Dec'10Dec'09
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss

-18,276

-26,457

-83,440

-29,365

58,037

-29,943

-27,790

-11,618

-36,529

-28,998

-31,440

Loss from discontinued operations

-

-

-

-189

85,319

3,355

6,947

-

-

-

-

Loss from continuing operations

-

-

-

-29,176

-27,282

-33,298

-34,737

-

-

-

-

Adjustments required to reconcile net loss to net cash used in operating activities:
Share based compensation

835

514

337

988

1,802

1,242

4,089

7,751

886

1,282

2,683

Depreciation

1,617

1,671

1,920

1,983

2,370

3,140

3,539

3,692

-

-

-

Depreciation and write down of fixed assets

-

-

-

-

-

-

-

-

3,631

3,133

1,990

Financial expenses (income), net (mainly exchange differences)

-378

-20

40

-13

-124

-1,446

264

171

-350

591

166

Changes in accrued liability for employee rights upon retirement

-10

-18

-18

10

59

140

200

276

155

377

265

Gain on amounts funded in respect of employee rights upon retirement

58

46

21

-7

-18

22

58

36

14

-

-

Loss on sale of fixed assets

-

-

-6

7

2

3

-

0

-8

0

-29

Loss on extinguishment of convertible notes

0

0

-1,325

14,063

0

-

-

-

-

-

-

Net loss (income) in connection with conversion of convertible notes

-

-213

116

-

-

-

-

-

-

-

-

Change in fair value of convertible notes embedded derivative

0

0

-38,061

-6,473

0

-

-

-

-

-

-

Gain on amounts funded in respect of employee rights upon retirement

-

-

-

-

-

-

-

-

-

26

81

Amortization of debt issuance costs and debt discount

2,991

2,602

2,334

568

445

444

127

0

0

-

-

Issuance of shares for interest payment in connection with conversions of convertible notes

0

234

2,391

-

-

-

-

-

-

-

-

Changes in operating assets and liabilities:
Increase (decrease) in contracts liability (including non-current portion)

-9,580

17,880

24,178

-411

-

-

-

-

-

-

-

Increase (decrease) in deferred revenues

-

-

-

-

362

886

-

1,281

-3,005

-4,563

64,612

Decrease (increase) in accounts receivable and other assets

-188

3,099

-25

1,133

-523

1,006

-2,238

-243

-3,891

6,860

1,224

Changes in right of use assets

110

-

-

-

-

-

-

-

-

-

-

Decrease (increase) in inventories

-414

736

2,588

-522

2,316

3,451

-

3,760

-910

1,189

-

Increase (decrease) in accounts payable and accruals

2,735

-761

4,902

2,139

-1,873

1,367

869

2,977

6,147

-1,029

7,784

Increase (decrease) in other long term liabilities

-482

241

750

-

-

-

-

-

-

-

-

Net cash used in continuing operations

-

-

-

-32,087

-25,770

-29,115

-23,997

635

-23,570

-

-

Net cash provided by discontinued operations

-

-

-

-11

1,486

-166

-6,656

-

-

-

-

Net cash used in operating activities

-19,358

-7,742

-9,994

-32,098

-24,284

-29,281

-30,653

-

-

-38,464

44,452

CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment

627

686

971

849

464

785

1,890

2,068

5,705

7,855

6,195

Proceeds from sale of property and equipment

-

-

3

20

3

11

-

0

2

0

73

Decrease (increase) in restricted deposit

259

-62

146

106

-45

90

42

80

0

-

-

Amounts funded in respect of employee rights upon retirement, net

-3

-33

5

32

96

137

170

138

165

137

52

Net cash used in continuing operations

-

-

-

-

-512

-1,001

-2,102

-2,286

-5,868

-

-

Net cash provided by discontinued operations

-

-

-

-

39,899

-

-

-

-

-

-

Net cash used in investing activities

-883

-591

-1,119

-967

39,387

-1,001

-2,102

-

-

-7,992

-6,174

CASH FLOWS FROM FINANCING ACTIVITIES:
Net payment for convertible notes

0

4,752

10,961

-

-

-

-

-

-

-

-

Net proceeds from issuance of convertible notes

-

-

9,542

19,681

-

0

66,780

0

0

-

-

Issuance of shares, net of issuance cost

-

-

-

-

6,101

-

-

25,328

20,650

0

-

Exercise of options

-

-

-

14

534

46

112

1,230

277

501

293

Net cash used in financing activities

-

-

-

-

-

46

66,892

26,558

20,927

-

-

Net cash used in financing activities

0

-4,752

-1,419

19,695

6,635

-

-

-

-

501

293

EFFECT OF EXCHANGE RATE CHANGES ON CASH AND CASH EQUIVALENTS

225

-270

414

277

-131

-1,395

226

127

-388

589

99

NET DECREASE IN CASH AND CASH EQUIVALENTS

-20,016

-13,355

-12,118

-

-

-

-

-

-

-

-

NET DECREASE IN CASH AND CASH EQUIVALENTS

-

-

-

-13,093

21,607

-31,631

34,363

25,034

-8,899

-45,366

38,670

SUPPLEMENTARY INFORMATION ON INVESTING AND FINANCING ACTIVITIES NOT INVOLVING CASH FLOWS:
Purchase of property and equipment

98

225

526

595

489

120

186

1,136

1,473

2,720

4,525

Issuance of promissory note

-

-

-

-

4,301

-

0

-

-

-

-

Issuance of common stock, net of issuance cost

-

-

-

6,848

-

-

-

-

-

-

-

Convertible note conversions

0

2,285

16,263

-

-

-

-

-

-

-

-

Right of use assets obtained in exchange for new operating lease liabilities

388

-

-

-

-

-

-

-

-

-

-

Issuance cost related to convertible note offering not yet paid

-

-

-

-

-

-

-

-

60

0

-

Exercise of options granted to employees

-

-

-

-

-

-

-

-

31

9

-

SUPPLEMENTARY DISCLOSURE ON CASH FLOWS
Interest paid

4,344

4,585

4,854

3,659

3,105

3,079

0

-

-

-

-